Peripheral Vascular Disease — Clinical Documentation Guide (2026)

🔍 Definition

Peripheral Vascular Disease (PVD) is a broad term encompassing diseases of the blood vessels outside the heart and brain — primarily the arteries and veins of the extremities, but also mesenteric and renal vasculature. In clinical coding practice, PVD most commonly refers to peripheral arterial disease (PAD), a manifestation of systemic atherosclerosis causing occlusion or stenosis of the arteries supplying the limbs. According to the CDC, approximately 6.5 million Americans age 40 and older have PAD.

The spectrum of PVD includes:

• Atherosclerotic PAD — most common; calcified plaque narrows arterial lumens, reducing perfusion. Coded to the highly specific ICD-10-CM I70.2xx–I70.9 subcategories, which require documentation of the vessel type, site, laterality, and severity (claudication → rest pain → ulceration → gangrene).
• Raynaud’s phenomenon/syndrome — episodic vasospasm of digital arteries and arterioles; coded I73.00 (without gangrene) or I73.01 (with gangrene).
• Thromboangiitis obliterans (Buerger’s disease) — inflammatory, non-atherosclerotic occlusion strongly associated with tobacco use; coded I73.1.
• Arterial embolism and thrombosis — acute occlusion by embolus or thrombus; I74.xx subcategories specify the vessel.
• Diabetic peripheral angiopathy — macrovascular complication of diabetes; always reported with an etiology-manifestation pair (e.g., E11.51 + I73.9 or E11.52 + I73.9 for with gangrene). See ICD-10-CM Official Guidelines.

Accurate severity documentation — specifically the Rutherford or Fontaine classification and the presence of claudication, rest pain, ulceration, or gangrene — is the single most important CDI lever because it drives both ICD-10-CM specificity and HCC risk-adjustment capture under CMS HCC model v28.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Clinical presentation depends on severity, location, and acuity of arterial insufficiency. The ACC/AHA 2024 Peripheral Vascular Diseases Guideline classifies PAD using the Rutherford and Fontaine systems:

• Asymptomatic PAD (Rutherford 0 / Fontaine I): Reduced ABI (<0.90) without symptoms; detectable on vascular studies. Document as atherosclerosis of extremity without documented symptoms if incidentally found.
• Intermittent claudication (Rutherford 1–3 / Fontaine IIa–IIb): Reproducible muscle cramping/fatigue with exertion, relieved by rest. Calf claudication → femoropopliteal disease; buttock/thigh claudication → aortoiliac (Leriche syndrome). This is the key ICD-10-CM 5th-digit distinction: “with intermittent claudication” subcategory.
• Ischemic rest pain (Rutherford 4 / Fontaine III): Constant burning pain in foot/toes at rest, worse at night, relieved by dependency. ABI typically <0.40. Must be documented to assign “with rest pain” subcategory codes.
• Tissue loss — ulceration (Rutherford 5 / Fontaine IV): Non-healing ischemic ulcers, typically on toes, heel, or distal foot. Distinct from venous stasis ulcers. Requires documentation of laterality and site for full ICD-10-CM specificity.
• Tissue loss — gangrene (Rutherford 6 / Fontaine IV): Dry or wet gangrene; constitutes critical limb-threatening ischemia. Triggers highest HCC weight under v28. Must be explicitly documented.

Additional signs include: diminished or absent peripheral pulses, cool/pale/mottled extremity, dependent rubor, atrophic skin changes, hair loss on dorsum of foot, delayed capillary refill, tissue necrosis, and abnormal ABI (<0.90 diagnostic; <0.40 critical ischemia; >1.30 suggests calcification requiring toe-brachial index). Acute limb ischemia presents with the classic “6 P’s.”

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

🦴 Anatomy & Pathophysiology

The peripheral arterial system supplying the lower extremities consists of a hierarchical tree: the abdominal aorta bifurcates into the common iliac arteries (external and internal branches), which become the common femoral artery at the inguinal ligament. The common femoral divides into the superficial femoral artery (SFA) (most commonly stenosed in femoropopliteal PAD) and the deep femoral (profunda femoris). The SFA becomes the popliteal artery behind the knee, which trifurcates into the anterior tibial, posterior tibial, and peroneal arteries (tibial/peroneal disease = infrapopliteal or “below-the-knee” PAD).

Atherosclerosis is the dominant pathophysiology: lipid-laden macrophages accumulate in the intima, forming foam cells and fibrous plaques. Progressive calcification, plaque rupture, and superimposed thrombosis reduce luminal diameter and distal perfusion pressure. When demand (exertion) exceeds limited supply, ischemic metabolite accumulation causes claudication. At rest pain stage, resting perfusion is inadequate; at gangrene stage, tissue necrosis is irreversible.

In Raynaud’s phenomenon, exaggerated vasospasm of digital arterioles — mediated by abnormal sympathetic and endothelial signaling — causes episodic triphasic color change. Secondary Raynaud’s (associated with scleroderma, lupus, or other connective tissue disease) carries higher risk of digital ischemia and gangrene (I73.01).

In Buerger’s disease (I73.1), transmural inflammatory infiltration of medium and small vessels — with skip lesions, giant cells, and organizing thrombus — results in distal limb ischemia distinct from atherosclerosis. Tobacco exposure is pathogenic; cessation is mandatory for disease control. According to NCBI StatPearls, Buerger’s disease affects upper and lower extremity vessels and can cause superficial thrombophlebitis.

Acute limb ischemia (I74.xx) results from sudden thromboembolism (often cardiac origin in atrial fibrillation) or in-situ thrombosis on a pre-existing plaque. Absent collateral circulation leads to rapid ischemic injury within 4–6 hours, making it a surgical emergency.

💊 Medication Impact / Treatment

Pharmacologic management of PVD directly influences coding by establishing diagnoses, indicating severity, and generating secondary conditions that require documentation:

• Antiplatelet agents (aspirin, clopidogrel/Plavix): Standard therapy for symptomatic PAD; dual antiplatelet post-revascularization. Document concurrent use for drug reconciliation.
• Statins (atorvastatin, rosuvastatin): Mandatory regardless of LDL level in PAD per AHA/ACC 2024 guidelines; document hyperlipidemia if present.
• ACE inhibitors / ARBs: Reduce cardiovascular events in PAD; also treat co-existing HTN — ensure both conditions are coded.
• Cilostazol (Pletal): Phosphodiesterase-3 inhibitor indicated for intermittent claudication (Rutherford 1–3); its use supports documentation of claudication severity and supports I70.2×1 coding.
• Vorapaxar (Zontivity): PAR-1 antagonist for secondary risk reduction in PAD; confirms PAD diagnosis.
• Rivaroxaban (low-dose) + aspirin: The COMPASS regimen for symptomatic PAD; indicates high-risk atherosclerotic disease.
• Prostaglandins (IV iloprost): Used in critical limb ischemia, Buerger’s disease, and severe Raynaud’s; suggests advanced disease severity.
• Thrombolytics (tPA, urokinase): Used in acute limb ischemia (I74.xx); supports acute coding with high urgency.
• Calcium channel blockers (nifedipine, amlodipine): First-line for Raynaud’s syndrome (I73.00/I73.01).
• Pentoxifylline: Rheologic agent for claudication; older use, now less preferred over cilostazol.

Documentation of wound care medications (silver sulfadiazine, becaplermin/Regranex for ischemic ulcers) supports tissue loss coding. Antibiotics for superinfected ischemic wounds trigger additional infection codes (confirm whether cellulitis or osteomyelitis is present — both are separately reportable).

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines (FY2026)

The following guidelines govern PVD coding under the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting (effective October 1, 2025):

1. Atherosclerosis Specificity (I70 subcategories)

ICD-10-CM requires maximum specificity for I70 codes. The hierarchy is: vessel type → site → laterality → severity. The 4th character identifies the vessel type (I70.2 = native arteries of extremities; I70.3 = bypass graft using autologous vein; I70.4–I70.7 = other graft types). The 5th character in I70.2xx–I70.7xx indicates severity:

• 1 = with intermittent claudication
• 2 = with rest pain
• 3 = with ulceration (requires additional code for ulcer site: L97.xxx or L98.49x)
• 4 = with gangrene (requires I96 if gangrene is separately documented)
• 9 = without symptoms / unspecified

When ulceration is present (5th digit 3), an additional code from L97 (non-pressure chronic ulcer of lower limb) or L98.49 (non-pressure chronic ulcer of skin at other site) must be assigned per the ICD-10-CM Tabular “use additional code” instruction. The L97 code captures the site and severity of the ulcer itself (heel, ankle, calf, toe, etc.).

2. Etiology-Manifestation: Diabetic PVD

Per ICD-10-CM Section I.C.4 (Endocrine, Nutritional, and Metabolic Diseases), “diabetic peripheral angiopathy” is coded with the diabetes code sequenced first (E11.51 type 2 without gangrene, E11.52 type 2 with gangrene), followed by I73.9 as the manifestation. The diabetic code contains a “use additional code” note for the underlying atherosclerosis when present. Do not assign I70.2xx as the primary code when the diabetes is the documented etiology — the E11.5x code captures that relationship.

3. Acute vs. Chronic Conditions

Acute limb ischemia from embolism or thrombosis is coded to I74.xx (embolism and thrombosis of arteries of extremities). Code I74.3 is the femoral artery, I74.4 the iliac, I74.5 for iliac/femoral combined, and I74.8 for other. When both acute and chronic (atherosclerotic) conditions are present, both codes are assigned — per ICD-10-CM Guideline I.C.9.a: acute conditions do not exclude the chronic underlying disease.

4. Atherosclerosis Due to Underlying Condition (I79.x)

I79.8 (Disorders of arteries, arterioles, and capillaries in diseases classified elsewhere) is used when atherosclerosis or PVD is documented as secondary to a classified disease such as hypothyroidism, collagen vascular disease, or other metabolic conditions. The underlying condition is coded first per the “code first” note in the I79 category.

5. Raynaud’s and Buerger’s Disease

Raynaud’s syndrome (I73.00 without gangrene; I73.01 with gangrene) — if secondary to a systemic condition (e.g., scleroderma M34.xx, SLE M32.xx), both codes are reported; the underlying condition is sequenced first in most contexts. Buerger’s disease (I73.1) does not have laterality or site extensions; the tobacco use/dependence code (F17.2xx) should also be reported per ICD-10-CM convention.

6. Laterality and Site Documentation Requirements

The I70.2xx subcategory codes require laterality (right = 1st position of 6th character in most subcodes; left = 2nd; bilateral = 3rd; unspecified = 9th). Coders must query when only “bilateral PAD” is documented without site specification. The ICD-10-CM Tabular provides explicit 7th-character extensions for ulcer site (e.g., I70.2311 = atherosclerosis native right leg with ulcer of thigh). Maximally specific codes require all digits to be assigned.

🔢 ICD-10-CM Code Set (FY2026)

🔎 Indexing

The ICD-10-CM Alphabetic Index provides the following primary entry pathways for PVD:

• Disease, peripheral vascular → I73.9
• Arteriosclerosis, arteriosclerotic (obliterans) (of) (senile) (with calcification) — extremities — native arteries — with — intermittent claudication → I70.211 (right), I70.212 (left), I70.213 (bilateral)
• Arteriosclerosis — extremities — native arteries — with — rest pain → I70.221, I70.222, I70.223
• Arteriosclerosis — extremities — native arteries — with — gangrene → I70.261, I70.262, I70.263
• Arteriosclerosis — bypass graft — autologous vein → I70.3xx series
• Raynaud’s syndrome → I73.00; Raynaud’s syndrome with gangrene → I73.01
• Thromboangiitis obliterans → I73.1; also see Buerger’s disease → I73.1
• Embolism — artery — lower extremity → I74.3 (femoral), I74.4 (iliac)
• Diabetes, diabetic — with — peripheral angiopathy — without gangrene → E11.51; with gangrene → E11.52
• Claudication, intermittent → I73.9 (if no atherosclerosis documented); confirm if atherosclerosis is the etiology before defaulting here
• Ischemia, peripheral → I73.9 (unspecified); query for specificity

🏥 CPT (2026)

🧾 HCPCS (2026)

📚 AHA Coding Clinic (Recent Guidance)

The following summarizes relevant AHA Coding Clinic guidance for PVD coding:

• Coding Clinic 4Q 2016: Clarified that when atherosclerosis of a native artery of the extremities causes ulceration, the coder must assign both the I70.2×3 code (with ulceration) AND an additional code from L97.xx to identify the ulcer site and severity. The I70.2×3 code alone is insufficient.
• Coding Clinic 2Q 2018: Confirmed that “critical limb ischemia” maps to I70.22x (with rest pain) or I70.26x (with gangrene) depending on the clinical presentation; the term “critical limb ischemia” alone is not a standalone code — documentation must specify whether rest pain, ulceration, or gangrene is present.
• Coding Clinic 3Q 2017: Addressed diabetic peripheral angiopathy coding — confirmed that E11.51/E11.52 is sequenced first as the etiology, followed by I73.9 as the manifestation. Do not assign atherosclerosis codes from I70.2xx for “diabetic PAD” unless the documentation separately establishes atherosclerosis as a distinct condition.
• Coding Clinic 1Q 2019: Clarified the coding of acute limb ischemia (I74.xx) combined with chronic atherosclerotic PAD — both codes are assigned, as the acute thromboembolism does not subsume the chronic underlying atherosclerosis.
• Coding Clinic 4Q 2019: Guidance on Buerger’s disease (I73.1) — confirmed that tobacco use/dependence codes (F17.2xx) should be assigned as additional codes, as tobacco is a documented causative agent. Cessation counseling (Z87.891) is also reportable when provided.
• Coding Clinic 2Q 2023: Updated guidance confirming that for bypass graft atherosclerosis, coders must identify the graft material type (autologous vein I70.3xx, autologous biological I70.4xx, nonautologous biological I70.5xx, nonbiological I70.6xx, other I70.7xx) from operative reports — physician documentation or query is required when graft type is not specified in current encounter notes.

💰 HCC / Risk Adjustment (v28)

Under CMS HCC Model v28 (effective 2024 payment year, phasing to full implementation by 2026), PVD codes map to the following HCCs:

✍️ CDI Query Templates

🧑‍⚕️ Treatments (Clinical)

Treatment of PVD follows a stepwise approach based on severity, as outlined in the ACC/AHA 2024 Peripheral Vascular Diseases Guideline:

Conservative / Medical Management

• Risk factor modification: Smoking cessation (mandatory for Buerger’s, critical for all PAD), glycemic control, blood pressure management, lipid-lowering therapy (statin + ezetimibe for high-risk PAD per ACC/AHA 2024).
• Supervised exercise therapy (SET): First-line for claudication (Rutherford 1–3); proven to increase walking distance as much as endovascular therapy. Requires structured program; improves collateral perfusion.
• Antiplatelet therapy: Aspirin 75–100 mg/day OR clopidogrel 75 mg/day (aspirin + rivaroxaban 2.5 mg BID = COMPASS regimen for high-risk PAD).
• Cilostazol 100 mg BID: Increases claudication walking distance; contraindicated in heart failure.

Endovascular Revascularization

• Percutaneous transluminal angioplasty (PTA): First-line for focal stenoses; CPT 37224 (femoropopliteal), 37220 (iliac), 37228 (tibial). Best outcomes in short segment, non-calcified lesions.
• Drug-coated balloon (DCB) angioplasty: Reduces restenosis in SFA/popliteal; CPT 37225 (atherectomy + angioplasty coding — verify specific code for DCB per AMA guidelines).
• Stenting: Iliac (covered stent preferred, CPT 37221), SFA (nitinol self-expanding, CPT 37226), tibial (rarely stented; CPT 37230).
• Atherectomy: Directional, orbital, rotational, or laser; CPT 37225 (femoropopliteal), 37229 (tibial add-on). Used in heavily calcified lesions.

Open Surgical Revascularization

• Aortobifemoral bypass (ABF): Gold standard for aortoiliac occlusive disease; CPT 35646; PTFE/Dacron graft; post-op ICD-10-CM I70.6xx (nonbiological bypass graft atherosclerosis) for subsequent stenosis.
• Femoral-popliteal bypass: Autologous saphenous vein preferred (CPT 35556); above or below knee. Post-op codes: I70.3xx (autologous vein graft) for future atherosclerosis.
• Femoral-tibial bypass: For infrapopliteal disease; limb salvage in CLI; CPT 35566. Vein conduit strongly preferred.
• Axillofemoral bypass: Extra-anatomic; high-risk patients unfit for aortic reconstruction; CPT 35621.
• Thromboendarterectomy: Plaque excision; CPT 35301 (carotid/vertebral) or 35381 for superficial femoral/popliteal.

Limb Salvage / Wound Care

• Advanced wound dressings, debridement (CPT 97597–97598), skin substitutes (Q4190), Unna boot (CPT 29581 for venous component).
• Hyperbaric oxygen therapy (CPT 99183) for ischemic/diabetic wounds — requires ABI documentation and failed revascularization confirmation.
• Amputation (CPT 27880–27592) as last resort for unsalvageable limb; document level and laterality explicitly.

Raynaud’s-Specific

• Calcium channel blockers (nifedipine ER), phosphodiesterase-5 inhibitors (sildenafil), IV iloprost for severe cases. Digital sympathectomy for refractory cases.

🎓 Patient Education / Summary

For patient-facing documentation and discharge instructions, consider the following key education points (based on CDC PAD patient education resources and American Heart Association PAD information):

• What is PAD? Peripheral artery disease means the arteries in your legs have become narrowed or blocked by plaque buildup, reducing blood flow to your muscles and feet.
• Know your symptoms: Leg cramping or pain when walking that goes away with rest (claudication); pain in your feet at rest, especially at night (critical stage); sores or wounds on your feet or toes that won’t heal; cold or discolored feet.
• Ankle-brachial index (ABI) test: A simple, painless test that compares blood pressure in your ankle to your arm to screen for PAD. An ABI below 0.9 indicates PAD.
• Risk factor control is treatment: Quitting smoking is the single most important action — it slows PAD progression dramatically. Controlling blood sugar (if diabetic), blood pressure, and cholesterol are equally critical.
• Exercise therapy works: A supervised walking program can improve your walking distance and quality of life significantly — sometimes as much as surgery.
• Foot care: Inspect feet daily for sores, blisters, or cuts. Wear proper footwear. Report any wounds immediately — ischemic ulcers can progress rapidly to gangrene.
• Medications: Take your blood thinners, statins, and blood pressure medications as prescribed. Cilostazol (Pletal) can help increase walking distance if you have claudication.
• When to seek emergency care: Sudden severe leg pain, pallor, cold limb, or loss of pulse — call 911 immediately. This may be an acute arterial occlusion requiring emergency surgery.

For CDI/coding use: Patient education documentation (discharge instructions, navigator notes) can support diagnosis coding when it references specific symptoms (rest pain, wound care instructions for ischemic ulcer) — ensure these notes are consistent with physician-documented diagnoses to withstand audit scrutiny.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)